Figure 4.
Kaplan-Meier analysis of PSA recurrence-free survival and negative, weak, moderate or strong SAM pointed domain-containing Ets transcription factor expression in (A) all cancer samples, (B) ERG fusion negative and (C) ERG fusion positive prostate cancer. Overall P-values are presented for all groups (log-rank test). ERG, ETS-related gene; PSA, prostate-specific antigen.